Hrobowski Tara, Lanfear David E
Henry Ford Heart and Vascular Institute, Henry Ford Hospital, Detroit, MI, USA.
Curr Heart Fail Rep. 2013 Mar;10(1):101-7. doi: 10.1007/s11897-012-0123-7.
The topic of this article, stated a more familiar way, is whether left ventricular assist devices (LVADs) are ready for 'Primetime' as a therapeutic option in and of themselves. In order to provide an update and insight on this question, we briefly review from where the field has come, and in more detail describe its current state and where we are heading. We believe the short answer to this question is 'Yes', but like many things, a short answer is not adequate. Here we attempt to deliver a more comprehensive answer, providing some historical context, outlining the great achievements that have been made, as well as the many challenges that still remain before LVADs become a truly mainstream therapy.
用一种更通俗易懂的方式来说，本文的主题是左心室辅助装置（LVADs）本身作为一种治疗选择是否已准备好进入“黄金时代”。为了就这个问题提供最新情况和见解，我们简要回顾一下该领域的发展历程，并更详细地描述其当前状况以及未来的发展方向。我们认为这个问题的简短答案是“是的”，但和许多事情一样，简短的答案并不够。在此，我们试图给出一个更全面的答案，提供一些历史背景，概述已经取得的巨大成就，以及在LVADs成为真正的主流疗法之前仍然存在的诸多挑战。
